Understanding Myosin Heavy Chain Gene Expression Differences in Mice and Humans
Author Information
Author(s): Harrison Brooke C, Allen David L, Leinwand Leslie A
Primary Institution: University of Colorado at Boulder
Hypothesis
What are the molecular mechanisms responsible for the differences in MyHC-IIb gene expression between mice and humans?
Conclusion
The study identifies genetic differences that explain why MyHC-IIb mRNA is expressed in fetal human muscle and up-regulated in Duchene muscular dystrophy patients, despite lower transcriptional activity compared to mice.
Supporting Evidence
- The human MyHC-IIb promoter has reduced transcriptional activity compared to the mouse promoter.
- MyHC-IIb mRNA is expressed in fetal human muscle cells and significantly up-regulated in Duchene muscular dystrophy patients.
- Differences in transcription factor binding sites account for the reduced activity of the human MyHC-IIb promoter.
Takeaway
This study looks at why a certain muscle protein is made differently in mice and humans, finding that humans can still make it under certain conditions, like when muscles are healing.
Methodology
The study involved comparing the transcriptional activity of the MyHC-IIb promoter in mouse and human muscle cells using transient transfection and electrophoretic mobility shift assays.
Limitations
The study did not provide compelling evidence of MyHC-IIb protein expression despite significant mRNA activation.
Participant Demographics
The study included human muscle biopsy samples from Duchene muscular dystrophy patients and healthy controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website